VALHALLA, New York, Aug. 4 -- Fujifilm, a manufacturer of cell culture media, reagents and medical devices, issued the following news release on Aug. 3, 2026:

* * *

Fujifilm and Taiho Pharmaceutical Enter into Strategic Partnership for Development of Next-Generation Antibody-Drug Conjugate (ADC) Manufacturing Technologies

Optimizing Manufacturing Processes to Enable Stable Production of High-Quality ADCs

-

TOKYO - FUJIFILM Corporat . . .

Click here for more information about our products